Gro-International to Develop BioElectronics' OTC Brands in European and African Markets

FREDERICK, Md., Feb. 14, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices is pleased to announce that Gro-International, SA, Geneva, Switzerland market developers and brand management have added ActiPatch® Musculoskeletal Pain Therapy, Allay™ Menstrual Pain Therapy, and the Smart Insole™ Heel Pain Therapy products to their select group of retail products portfolio.  The Gro-International management team has a substantial history building successful brands, as well as developing and implementing marketing strategies.

The Gro-International team includes Gregor Forbes, Ivan Tsibulsky, and Paul Screawn.  Mr. Forbes has over 28 years of experience in Fast Moving Consumer Goods (FMCG) and over-the-counter pharmaceuticals including 25 years at Procter & Gamble where he was General Manager of Global Development markets, and as a non executive director of Swiss Precision Diagnostics.  Mr. Screawn is the former Commercial Director, Global Development Markets Central & Eastern Europe, Middle East and Africa at Procter & Gamble.

Gro-International has developed a network of experienced brand managers covering the nine major markets that recruit and manage distributors, sales agents, advertising and marketing to enhance local brand development. In addition to recruiting new distributors, Gro-International will assume management responsibility for BioElectronics' new and existing distributors in the United Kingdom, Denmark, Malta, Spain, Balkans, Bulgaria, Greece, Cyprus, Czech Republic, Nigeria, Morocco, and South Africa.

Paul Screawn commented, "We have done extensive market research, competitive evaluations, and product analysis on BioElectronics' pain products.  We are eager to move these products to the next stage and fully develop this unique market opportunity. The new devices, pricing, safety, and the market demand for an exceptional painkiller, provides a profound market opportunity."

Andrew Whelan, CEO of BioElectronics stated, "This Agreement with Gro-International provides market coverage for in excess of 400,000 professional pharmacies which covers fifty percent (50%) of the medical device market. Most importantly, the principals of Gro-International have lived and worked in these markets and know the distributors and the cultures."

About BioElectronics Corporation
Drugs and heat patches provide temporary minimal pain relief by simply masking it but it always comes back.  ActiPatch provides 5x better pain relief and is 100% safer than over-the-counter drugs. BioElectronics Corporation is an award winning medical device developer and manufacturer of advanced medical devices.  Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ menstrual cycle pain therapy, and RecoveryRx™ for surgical procedures and wound care.  The unique therapy delivery system, using patented technology, provides a cost-effective in-home option to reduce soft tissue pain and inflammation, and to accelerate healing. For more information, please see www.bielcorp.com   

Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com   

SOURCE BioElectronics Corporation



RELATED LINKS
http://www.bielcorp.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.